|
US5118800A
(en)
|
1983-12-20 |
1992-06-02 |
California Institute Of Technology |
Oligonucleotides possessing a primary amino group in the terminal nucleotide
|
|
FR2567892B1
(fr)
|
1984-07-19 |
1989-02-17 |
Centre Nat Rech Scient |
Nouveaux oligonucleotides, leur procede de preparation et leurs applications comme mediateurs dans le developpement des effets des interferons
|
|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
|
US5166315A
(en)
|
1989-12-20 |
1992-11-24 |
Anti-Gene Development Group |
Sequence-specific binding polymers for duplex nucleic acids
|
|
US5185444A
(en)
|
1985-03-15 |
1993-02-09 |
Anti-Gene Deveopment Group |
Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages
|
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
|
US5591722A
(en)
|
1989-09-15 |
1997-01-07 |
Southern Research Institute |
2'-deoxy-4'-thioribonucleosides and their antiviral activity
|
|
ATE190981T1
(de)
|
1989-10-24 |
2000-04-15 |
Isis Pharmaceuticals Inc |
2'-modifizierte nukleotide
|
|
US5670633A
(en)
|
1990-01-11 |
1997-09-23 |
Isis Pharmaceuticals, Inc. |
Sugar modified oligonucleotides that detect and modulate gene expression
|
|
US5646265A
(en)
|
1990-01-11 |
1997-07-08 |
Isis Pharmceuticals, Inc. |
Process for the preparation of 2'-O-alkyl purine phosphoramidites
|
|
GB9009980D0
(en)
|
1990-05-03 |
1990-06-27 |
Amersham Int Plc |
Phosphoramidite derivatives,their preparation and the use thereof in the incorporation of reporter groups on synthetic oligonucleotides
|
|
ES2116977T3
(es)
|
1990-05-11 |
1998-08-01 |
Microprobe Corp |
Soportes solidos para ensayos de hibridacion de acidos nucleicos y metodos para inmovilizar oligonucleotidos de modo covalente.
|
|
US6582908B2
(en)
|
1990-12-06 |
2003-06-24 |
Affymetrix, Inc. |
Oligonucleotides
|
|
DE59208572D1
(de)
|
1991-10-17 |
1997-07-10 |
Ciba Geigy Ag |
Bicyclische Nukleoside, Oligonukleotide, Verfahren zu deren Herstellung und Zwischenprodukte
|
|
US5359044A
(en)
|
1991-12-13 |
1994-10-25 |
Isis Pharmaceuticals |
Cyclobutyl oligonucleotide surrogates
|
|
DK0618925T4
(da)
|
1991-12-24 |
2012-07-09 |
Isis Pharmaceuticals Inc |
Antisense-oligonukleotider
|
|
FR2687679B1
(fr)
|
1992-02-05 |
1994-10-28 |
Centre Nat Rech Scient |
Oligothionucleotides.
|
|
EP0577558A2
(de)
|
1992-07-01 |
1994-01-05 |
Ciba-Geigy Ag |
Carbocyclische Nukleoside mit bicyclischen Ringen, Oligonukleotide daraus, Verfahren zu deren Herstellung, deren Verwendung und Zwischenproduckte
|
|
JPH08508492A
(ja)
|
1993-03-30 |
1996-09-10 |
スターリング ウィンスロップ インコーポレイティド |
非環式ヌクレオシド類似体及びそれらを含むオリゴヌクレオチド配列
|
|
US5801154A
(en)
|
1993-10-18 |
1998-09-01 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of multidrug resistance-associated protein
|
|
US5446137B1
(en)
|
1993-12-09 |
1998-10-06 |
Behringwerke Ag |
Oligonucleotides containing 4'-substituted nucleotides
|
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
|
US5627053A
(en)
|
1994-03-29 |
1997-05-06 |
Ribozyme Pharmaceuticals, Inc. |
2'deoxy-2'-alkylnucleotide containing nucleic acid
|
|
US5597909A
(en)
|
1994-08-25 |
1997-01-28 |
Chiron Corporation |
Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use
|
|
US5681940A
(en)
*
|
1994-11-02 |
1997-10-28 |
Icn Pharmaceuticals |
Sugar modified nucleosides and oligonucleotides
|
|
WO2005121368A1
(en)
|
2004-06-03 |
2005-12-22 |
Isis Pharmaceuticals, Inc. |
Chimeric gapped oligomeric compositions
|
|
US6770748B2
(en)
|
1997-03-07 |
2004-08-03 |
Takeshi Imanishi |
Bicyclonucleoside and oligonucleotide analogue
|
|
JP3756313B2
(ja)
|
1997-03-07 |
2006-03-15 |
武 今西 |
新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
|
|
ATE293123T1
(de)
|
1997-09-12 |
2005-04-15 |
Exiqon As |
Bi- und tri-zyklische - nukleosid, nukleotid und oligonukleotid-analoga
|
|
US6794499B2
(en)
|
1997-09-12 |
2004-09-21 |
Exiqon A/S |
Oligonucleotide analogues
|
|
US20030228597A1
(en)
|
1998-04-13 |
2003-12-11 |
Cowsert Lex M. |
Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulation
|
|
US6043352A
(en)
|
1998-08-07 |
2000-03-28 |
Isis Pharmaceuticals, Inc. |
2'-O-Dimethylaminoethyloxyethyl-modified oligonucleotides
|
|
US5998148A
(en)
|
1999-04-08 |
1999-12-07 |
Isis Pharmaceuticals Inc. |
Antisense modulation of microtubule-associated protein 4 expression
|
|
ATE356824T1
(de)
|
1999-05-04 |
2007-04-15 |
Santaris Pharma As |
L-ribo-lna analoge
|
|
US6525191B1
(en)
|
1999-05-11 |
2003-02-25 |
Kanda S. Ramasamy |
Conformationally constrained L-nucleosides
|
|
WO2001049687A2
(en)
|
1999-12-30 |
2001-07-12 |
K. U. Leuven Research & Development |
Cyclohexene nucleic acids
|
|
USH2191H1
(en)
|
2000-10-24 |
2007-06-05 |
Snp Consortium |
Identification and mapping of single nucleotide polymorphisms in the human genome
|
|
US20050019915A1
(en)
|
2001-06-21 |
2005-01-27 |
Bennett C. Frank |
Antisense modulation of superoxide dismutase 1, soluble expression
|
|
WO2003004602A2
(en)
|
2001-07-03 |
2003-01-16 |
Isis Pharmaceuticals, Inc. |
Nuclease resistant chimeric oligonucleotides
|
|
US7696345B2
(en)
|
2002-11-05 |
2010-04-13 |
Isis Pharmaceuticals, Inc. |
Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
|
|
WO2004044133A2
(en)
|
2002-11-05 |
2004-05-27 |
Isis Pharmaceuticals, Inc. |
Modified oligonucleotides for use in rna interference
|
|
ATE517992T1
(de)
|
2002-11-14 |
2011-08-15 |
Dharmacon Inc |
Funktionelle und hyperfunktionelle sirna
|
|
US7250496B2
(en)
|
2002-11-14 |
2007-07-31 |
Rosetta Genomics Ltd. |
Bioinformatically detectable group of novel regulatory genes and uses thereof
|
|
US7790867B2
(en)
|
2002-12-05 |
2010-09-07 |
Rosetta Genomics Inc. |
Vaccinia virus-related nucleic acids and microRNA
|
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
|
DK1661905T3
(da)
|
2003-08-28 |
2012-07-23 |
Takeshi Imanishi |
Hidtil ukendte syntetiske nukleinsyrer af N-O-krydsbindingstype
|
|
AU2004274021B2
(en)
|
2003-09-18 |
2009-08-13 |
Isis Pharmaceuticals, Inc. |
4'-thionucleosides and oligomeric compounds
|
|
US20050261233A1
(en)
|
2004-04-21 |
2005-11-24 |
Sanjay Bhanot |
Modulation of glucose-6-phosphatase translocase expression
|
|
KR20070085113A
(ko)
|
2004-05-11 |
2007-08-27 |
가부시키가이샤 알파젠 |
Rna간섭을 생기게 하는 폴리뉴클레오티드, 및 이를 이용한유전자발현억제 방법
|
|
CA2568735A1
(en)
|
2004-06-03 |
2005-12-22 |
Isis Pharmaceuticals, Inc. |
Double strand compositions comprising differentially modified strands for use in gene modulation
|
|
EP1812569A2
(en)
|
2004-11-08 |
2007-08-01 |
K.U. Leuven Research and Development |
Modified nucleosides for rna interference
|
|
ES2453380T3
(es)
|
2006-01-26 |
2014-04-07 |
Isis Pharmaceuticals, Inc. |
Composiciones y utilizaciones dirigidas hacia la huntingtina
|
|
AU2007211080B9
(en)
|
2006-01-27 |
2012-05-03 |
Isis Pharmaceuticals, Inc. |
6-modified bicyclic nucleic acid analogs
|
|
US8586554B2
(en)
|
2006-05-05 |
2013-11-19 |
Isis Pharmaceuticals, Inc. |
Compounds and methods for modulating expression of PTP1B
|
|
WO2007134181A2
(en)
|
2006-05-11 |
2007-11-22 |
Isis Pharmaceuticals, Inc. |
5'-modified bicyclic nucleic acid analogs
|
|
JP2010505432A
(ja)
|
2006-10-09 |
2010-02-25 |
サンタリス ファーマ アー／エス |
Ｐｃｓｋ９を調節するためのｒｎａアンタゴニスト化合物
|
|
CN101563458A
(zh)
|
2006-12-14 |
2009-10-21 |
诺瓦提斯公司 |
治疗肌肉和心血管病症的组合物和方法
|
|
WO2008101157A1
(en)
|
2007-02-15 |
2008-08-21 |
Isis Pharmaceuticals, Inc. |
5'-substituted-2'-f modified nucleosides and oligomeric compounds prepared therefrom
|
|
CA2688321A1
(en)
|
2007-05-30 |
2008-12-11 |
Isis Pharmaceuticals, Inc. |
N-substituted-aminomethylene bridged bicyclic nucleic acid analogs
|
|
US8278426B2
(en)
|
2007-06-08 |
2012-10-02 |
Isis Pharmaceuticals, Inc. |
Carbocyclic bicyclic nucleic acid analogs
|
|
ATE462787T1
(de)
|
2007-06-18 |
2010-04-15 |
Commissariat Energie Atomique |
Reversibles sirna-silencing eines mutierten und endogenen huntington-wildtypgens und dessen anwendung zur behandlung von morbus huntington
|
|
CN101796062B
(zh)
|
2007-07-05 |
2014-07-30 |
Isis制药公司 |
6-双取代双环核酸类似物
|
|
US20090123928A1
(en)
|
2007-10-11 |
2009-05-14 |
The Johns Hopkins University |
Genomic Landscapes of Human Breast and Colorectal Cancers
|
|
AU2008324068A1
(en)
*
|
2007-11-05 |
2009-05-14 |
Baltic Technology Development, Ltd. |
Use of oligonucleotides with modified bases in hybridization of nucleic acids
|
|
US8546556B2
(en)
|
2007-11-21 |
2013-10-01 |
Isis Pharmaceuticals, Inc |
Carbocyclic alpha-L-bicyclic nucleic acid analogs
|
|
WO2009100320A2
(en)
|
2008-02-07 |
2009-08-13 |
Isis Pharmaceuticals, Inc. |
Bicyclic cyclohexitol nucleic acid analogs
|
|
WO2010036698A1
(en)
|
2008-09-24 |
2010-04-01 |
Isis Pharmaceuticals, Inc. |
Substituted alpha-l-bicyclic nucleosides
|
|
EP2361256B1
(en)
|
2008-09-24 |
2013-04-10 |
Isis Pharmaceuticals, Inc. |
Cyclohexenyl nucleic acid analogs
|
|
US20120149757A1
(en)
|
2009-04-13 |
2012-06-14 |
Krainer Adrian R |
Compositions and methods for modulation of smn2 splicing
|
|
WO2010121074A1
(en)
*
|
2009-04-15 |
2010-10-21 |
Isis Pharmaceuticals, Inc. |
Modulation of inflammatory responses by factor xi
|
|
CN104651408A
(zh)
|
2009-06-15 |
2015-05-27 |
阿尔尼拉姆医药品有限公司 |
靶向pcsk9基因的脂质配制的dsrna
|
|
CA2767231A1
(en)
|
2009-07-06 |
2011-01-13 |
Alnylam Pharmaceuticals, Inc. |
Cell-based bioprocessing
|
|
US8927513B2
(en)
|
2009-07-07 |
2015-01-06 |
Alnylam Pharmaceuticals, Inc. |
5′ phosphate mimics
|
|
WO2011017521A2
(en)
|
2009-08-06 |
2011-02-10 |
Isis Pharmaceuticals, Inc. |
Bicyclic cyclohexose nucleic acid analogs
|
|
WO2011135396A1
(en)
|
2010-04-30 |
2011-11-03 |
Cellectis |
Method for modulating double-strand break-induced homologous recombination
|
|
WO2012005898A2
(en)
|
2010-06-15 |
2012-01-12 |
Alnylam Pharmaceuticals, Inc. |
Chinese hamster ovary (cho) cell transcriptome, corresponding sirnas and uses thereof
|
|
EP2595663A4
(en)
*
|
2010-07-19 |
2014-03-05 |
Isis Pharmaceuticals Inc |
MODULATION OF DYSTROPHIA MYOTONICA PROTEIN KINASE (DMPK) EXPRESSION
|
|
CA2817960C
(en)
*
|
2010-11-17 |
2020-06-09 |
Isis Pharmaceuticals, Inc. |
Modulation of alpha synuclein expression
|
|
DK2655621T3
(en)
|
2010-12-20 |
2018-08-13 |
Massachusetts Gen Hospital |
Polycomb-associated non-coding RNAS
|
|
WO2012092367A1
(en)
|
2010-12-28 |
2012-07-05 |
University Of Rochester |
Nucleic acid binding compounds, methods of making, and use thereof
|
|
WO2012135736A2
(en)
*
|
2011-04-01 |
2012-10-04 |
Isis Pharmaceuticals, Inc. |
Modulation of signal transducer and activator of transcription 3 (stat3) expression
|
|
SG194555A1
(en)
*
|
2011-04-21 |
2013-12-30 |
Isis Pharmaceuticals Inc |
Modulation of hepatitis b virus (hbv) expression
|
|
WO2013030588A1
(en)
|
2011-08-31 |
2013-03-07 |
The University Of Manchester |
Method for diagnosing a neurodegenerative disease
|
|
WO2013036833A1
(en)
|
2011-09-09 |
2013-03-14 |
Mayo Foundation For Medical Education And Research |
Detecting frontotemporal dementia and amyotrophic lateral sclerosis
|
|
US8901098B2
(en)
*
|
2011-10-25 |
2014-12-02 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of GCCR expression
|
|
EP2780474A4
(en)
*
|
2011-11-17 |
2015-06-17 |
Rheonix Inc |
SYSTEM AND METHOD FOR SELECTIVE MOLECULAR ANALYSIS
|
|
EP3858847A1
(en)
|
2011-11-30 |
2021-08-04 |
Sarepta Therapeutics, Inc. |
Oligonucleotides for treating expanded repeat diseases
|
|
CA2858576A1
(en)
|
2011-12-06 |
2013-06-13 |
Research Institute At Nationwide Children's Hospital |
Non-ionic, low osmolar contrast agents for delivery of antisense oligonucleotides and treatment of disease
|
|
ES2983421T3
(es)
|
2012-04-23 |
2024-10-23 |
Vico Therapeutics B V |
Oligonucleótidos moduladores de ARN con características mejoradas para el tratamiento de trastornos neuromusculares
|
|
RU2624028C2
(ru)
*
|
2012-05-24 |
2017-06-30 |
Ионис Фармасьютикалз, Инк. |
Способы и композиции для модулирования экспрессии аполипопротеина (а)
|
|
FI2906696T4
(fi)
|
2012-10-15 |
2023-03-18 |
|
Menetelmiä c9orf72:n ilmentymisen moduloimiseksi
|
|
AU2013331434B2
(en)
*
|
2012-10-15 |
2019-08-08 |
Ionis Pharmaceuticals, Inc. |
Compositions for modulating C90RF72 expression
|
|
EP2906697A4
(en)
*
|
2012-10-15 |
2016-06-22 |
Ionis Pharmaceuticals Inc |
METHOD FOR MONITORING THE C9ORF72 EXPRESSION
|
|
DK2948777T3
(da)
|
2013-01-22 |
2019-09-23 |
Deutsches Zentrum Fuer Neurodegenerative Erkrankungen E V |
Dipeptid-repeat-proteiner som terapeutisk mål i neurodegenerative sygdomme med hexanukleotid-repeat-udvidelse
|
|
CN112080502A
(zh)
|
2013-10-11 |
2020-12-15 |
Ionis制药公司 |
用于调节c9orf72表达的组合物
|
|
WO2016024205A1
(en)
*
|
2014-08-15 |
2016-02-18 |
Pfizer Inc. |
Oligomers targeting hexanucleotide repeat expansion in human c9orf72 gene
|
|
WO2016060919A1
(en)
|
2014-10-14 |
2016-04-21 |
The Board Of Regents Of The University Of Texas System |
Allele selective inhibition of mutant c9orf72 foci expression by duplex rnas targeting the expanded hexanucleotide repeat
|
|
WO2017079291A1
(en)
|
2015-11-02 |
2017-05-11 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for modulating c90rf72
|
|
EP3443094B1
(en)
|
2016-04-13 |
2022-10-19 |
Ionis Pharmaceuticals, Inc. |
Methods for reducing c9orf72 expression
|
|
US10399845B2
(en)
|
2017-09-22 |
2019-09-03 |
Emco Wheaton Retail Corporation |
Testable overfill prevention valve for a liquid storage container
|